Trial intelligence / Profile preview

Altoderm sodium cromoglicate lotion in paediatric atopic dermatitis (vehicle-controlled, double-blind, randomized)

2008-005469-67Phase 3Completed

Sponsor
Thornton & Ross
Start
Jan 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of alclometasone in atopic dermatitis (AD) (2 arms), sponsored by Thornton & Ross. Primary endpoint: Total SCORAD. Started Jan 2009; status: completed.

02

Drugs

alclometasone
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2008-005469-67.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005469-67.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call